参考文献/References:
[1] SUNG H,FERIAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] CHEN W,SUN K,ZHENG R,et al.Cancer incidence and mortality in China,2014[J].Chin J Cancer Res,2018,30(1):1-12.
[3] 刘鑫,张锦,袁东红,等.复生康胶囊联合高强度聚焦超声消融术治疗胃癌肝转移临床研究[J].陕西中医,2020,41(2):164-167.
[4] WU C,LI M,MENG H,et al.Analysis of status ancl countermeasures of cancer incidence and mortality in China[J].Sci China Life Sci,2019,62(5):640-647.
[5] 余伟,高怀军.腹腔镜与传统开腹根治术治疗进展期胃癌临床效果对比研究[J].陕西医学杂志,2019,48(11):1471-1473,1551.
[6] 吴水清,黄建成,李达周,等.OLGA及OLGIM分期系统对1790例慢性萎缩性胃炎患者胃癌风险的评估价值[J].陕西医学杂志,2021,50(6):756-758.
[7] 沈海燕,乐敏,虞朝辉,等.共聚焦激光显微内镜对溃疡性结肠炎肠黏膜修复的病理改变评估[J].中华消化内镜杂志,2018,35(3):185-189.
[8] SUMIYAMA K.Erratum to:Past and current trends in endoscopic diagnosis for early stage gastric cancer injapan[J].Gastric Cancer,2017,20(3):562.
[9] CHOI J,KIM S G,IM J P,et al.Endoscopic prediction of tumor invasion depth in early gastric cancer[J].Gastrointest Endosc,2011,73(5):917-927.
[10] 商倩,张诗彤,邱志兵,等.255例早期胃癌临床病理及蓝激光成像结合放大内镜下的特征分析[J].中华消化内镜杂志,2018,35(10):740-744.
[11] YOSHIDA S,TANAKA S,KUNIHIRO K,et al.Diagnostic ability of highfrequency ultrasound probe sonography in staging early gastric cancer,especially for submucosal invasion[J].Abdom Imaging,2005,30(5):518-523.
[12] LEE J Y,CHOIL J,KIM C C,et al.Therapeutic decision-making using endoscopic ultrasonography in endoscopic treatment of early gastric cancer[J].Gut Liver,2016,10(1):42-50.
[13] ROBLES-MEDRANDA C,VARGAS M,OSPINA J,et al.Clinical impact of confocal laser endomicroscopy in the management of gastrointestinal lesions with an uncertain diagnosis[J].World J Castrointest Endosc,2017,9(8):389-395.
[14] ZHANG H P,YANG S,CHEN W H,et al.The diagnostic value of confocal laser endomicroscopy for gastric cancer and precancerous lesions among Asian population:A system review and metaanalysis[J].Scand J Gastroenterol,2017,52(4):382-388.
[15] 杨梅,原丽莉.内镜下早期胃癌的诊疗进展分析[J].国际老年医学杂志,2022,43(5):627-630.
[16] PITTAYANON R,RERKNIMITR R.Role of digital chromoendoscopy and confocal laser endomicroscopy for gastric intestinal metaplasia and cancer surveillance[J].World J Gastrointest Endosc,2012,4(10):472-478.
[17] INOKI K,ABE S,TANAKA Y,et al.Reduced intravenous fluorescein dose for upper and lower gastrointestinal tract probebased confocal laser endomicroscopy[J].Clin Endosc,2021,54(3):363-370.
[18] 左秀丽,李延青.探头式共聚焦激光显微内镜在体诊断胃黏膜肠上皮化生和胃肿瘤的多中心、随机对照研究[J].中华内科杂志,2018,57(2):146.
[19] JAPANESE GASTRIC CANCER ASSOCIATION.Japanese gastric cancer treatment guidelines 2010(ver.3)[J].Gastric Cancer,2011,14(2):113-123.
[20] LI W B,ZUO X L,LI C O,et al.Diagnostic value of confocal laser endomicroscopy for gastric superficial cancerous lesions[J].Gut,2011,60(3):299-306.
[21] 马盼盼,蔡利军,吕宾,等.探头式激光共聚焦显微内镜在胃癌及癌前病变临床诊断中的作用[J].浙江大学学报(医学版),2019,48(5):504-510.
[22] ZHANG H P,YANG S,CHEN W H,et al.The diagnostic value of confocal laser endomicroscopy for gastric cancer and precancerous lesions among Asian population:A system review and metaanalysis[J].Scand J Gastroenterol,2017,52(4):382-388.
[23] PARK C H,KIM H,JO J H,et al.Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancer[J].J Gastroenterol Hepatol,2019,34(1):84-91.
[24] YU X,CHEN J,ZHENG L,et al.Quantitative diagnosis of atrophic gastritis by probe-based confocal laser endomicroscopy[J].Biomed Res Int,2020,2020:9847591.
[25] DIAS-NETO M,PINTALHAO M,FERREIRA M,et al.Salt intake and risk of gastric intestinal metaplasia:Systematic review and meta-analysis[J].Nutr Cancer,2010,62(2):133-147.
[26] TERADA T,TAHARA T,HASHIMOTO S,et al.Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy in gastrointestinal subepithelial lesions:Feasibility study[J].Dig Endosc,2020,32(4):574-584.
[27] NAGAHAMA T,YAO K,MAKI S,et al.Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy(with video)[J].Gastrointest Endosc,2011,74(6):1259-1267.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(7):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(7):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(7):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(7):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(7):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(7):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(7):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(7):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
[11]张兴旺,马艳梅,朱 静△.早期胃癌及癌前病变组织中LC3、Ki-67、SOX9的表达及临床意义*[J].陕西医学杂志,2020,49(11):1519.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.039]
ZHANG Xingwang,MA Yanmei,ZHU Jing..The expression and clinical significance of LC3,Ki-67 and SOX9in early gastric cancer and precancerous lesions[J].,2020,49(7):1519.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.039]
[12]王 洁,张云清,赵 斌,等.K-ras诱导细胞衰老与胃癌及癌前病变关系研究[J].陕西医学杂志,2021,50(3):370.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.030]
WANG Jie,ZHANG Yunqing,ZHAO Bin,et al.Relationship between K-ras-induced cellular senescence and gastric cancer and precancerous lesions[J].,2021,50(7):370.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.030]